Skip to content
info@sayretherapeutics.com
Linkedin
Youtube
Facebook
Instagram
X-twitter
Home
Partnerships
Partners
Why Sayre?
Novels
Special Programs
Dinutuximab Beta
Neratinib
Darinaparsin
Carmustine Wafers
5-ALA
Dexrazoxane
Asparaginase Erwinia Chrysanthemi
Foscarnet
Mitotane
Electric Field Therapy
TARE
Commercially Approved Products
DC Bead
Cryoablation
Lymphoaim
Diagnostics
Tempus
BGI
Biosimilars
RasCase
PegNustim
MejorAsp
Niche Generics
CelstemX
Octri-Lar
Caveolin-Ptx
Du-Kinib
Solfredoc RTU
Cladtrios
Blogs
About Us
Careers
Contact Us
X
Tempus
Home
About
AI-enabled Precision Medicine
Bringing the power of data and artificial intelligence to healthcare
LEADING DIAGNOSTIC COMPANY PROVIDING
PREDICTIVE
PROGNOSTIC
TREATMENTS
PERSONALISED
TREATMENTS
Our Products
xT: SOLID TUMOR
Solid Tumor and hematologic malignancies
648 Genes analyzed
Incidental Germline (Tumor Normal Match)
DNA + RNA transcriptome validated fusion detection
Immune Biomarkers- TMB, MSI
xE: WHOLE EXOME
19000+ Genes analyzed
Solid tumor and hematologic malignancies
Incidental Germline (Tumor Normal Match)
DNA + RNA transcriptome validated fusion detection
Immune Biomarkers- TMB, MSI
xF: LIQUID BIOPSY
Solid Tumor only
105 genes analyzed
Immune biomarkers- MSI high
Auto-conversion options from xT in event of tissue NGS failure/QNS
More Information
Contact Us
Name
Email
Phone
Question
SUBMIT
OR
Contact us at:
+91 9591736262
Email us at
info@sayretherapeutics.com